- Home
- BRBR vs MEDP Comparison
BRBR vs MEDP Comparison
Compare BRBR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- MEDP
- Stock Information
- Founded
- BRBR 2019
- MEDP 1992
- Country
- BRBR United States
- MEDP United States
- Employees
- BRBR N/A
- MEDP N/A
- Industry
- BRBR Packaged Foods
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BRBR Consumer Staples
- MEDP Health Care
- Exchange
- BRBR Nasdaq
- MEDP Nasdaq
- Market Cap
- BRBR 8.8B
- MEDP 8.3B
- IPO Year
- BRBR 2019
- MEDP 2016
- Fundamental
- Price
- BRBR $62.96
- MEDP $294.90
- Analyst Decision
- BRBR Strong Buy
- MEDP Hold
- Analyst Count
- BRBR 18
- MEDP 10
- Target Price
- BRBR $77.56
- MEDP $343.22
- AVG Volume (30 Days)
- BRBR 2.8M
- MEDP 333.7K
- Earning Date
- BRBR 05-05-2025
- MEDP 07-21-2025
- Dividend Yield
- BRBR N/A
- MEDP N/A
- EPS Growth
- BRBR 49.75
- MEDP 33.36
- EPS
- BRBR 2.14
- MEDP 13.09
- Revenue
- BRBR $2,192,100,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- BRBR $17.77
- MEDP $5.59
- Revenue Next Year
- BRBR $11.06
- MEDP $3.46
- P/E Ratio
- BRBR $29.39
- MEDP $22.53
- Revenue Growth
- BRBR 18.91
- MEDP 9.87
- 52 Week Low
- BRBR $48.06
- MEDP $250.05
- 52 Week High
- BRBR $80.67
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- BRBR 42.52
- MEDP 46.73
- Support Level
- BRBR $60.09
- MEDP $293.51
- Resistance Level
- BRBR $63.84
- MEDP $302.32
- Average True Range (ATR)
- BRBR 2.07
- MEDP 9.27
- MACD
- BRBR -0.02
- MEDP -0.39
- Stochastic Oscillator
- BRBR 45.48
- MEDP 33.56
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.